One CoIT recipient (2.6%) and one PoIIT recipient (1.1%) experienced hyperkalemia (>5.5 mEq/L) during the intraoperative postreperfusion phase (p = 0.518), and were managed with an additional bolus insulin injection. Here, INS is linked to Hyperkalemia.